XML 14 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Document And Entity Information - USD ($)
$ in Millions
 12 Months Ended
Sep. 30, 2023
Dec. 27, 2023
Mar. 31, 2023
Document Information Line Items      
Entity Registrant Name Citius Pharmaceuticals, Inc.    
Trading Symbol CTXR    
Document Type 10-K    
Current Fiscal Year End Date --09-30    
Entity Common Stock, Shares Outstanding   158,966,576  
Entity Public Float     $ 156.9
Amendment Flag false    
Entity Central Index Key 0001506251    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Well-known Seasoned Issuer No    
Document Period End Date Sep. 30, 2023    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
ICFR Auditor Attestation Flag false    
Document Annual Report true    
Document Transition Report false    
Entity File Number 001-38174    
Entity Incorporation, State or Country Code NV    
Entity Tax Identification Number 27-3425913    
Entity Address, Address Line One 11 Commerce Drive    
Entity Address, Address Line Two First Floor    
Entity Address, City or Town Cranford    
Entity Address, State or Province NJ    
Entity Address, Postal Zip Code 07016    
City Area Code (908)    
Local Phone Number 967-6677    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Security Exchange Name NASDAQ    
Entity Interactive Data Current Yes    
Document Financial Statement Error Correction [Flag] false    
Documents Incorporated by Reference [Text Block]

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the Company’s Proxy Statement for the Annual Meeting of Stockholders expected to be held in March 2024 are incorporated by reference in Part III of this Report.

    
Auditor Firm ID 392    
Auditor Name Wolf & Company, P.C.    
Auditor Location Boston, Massachusetts